电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

MORF4 抗体 (Middle Region)

This anti-MORF4 antibody is a 兔 多克隆 antibody detecting MORF4 in WB. Suitable for 人, 小鼠, 大鼠, 犬, Cow, 非洲爪蟾 和 斑马鱼.
产品编号 ABIN928181
发货至: 中国

Quick Overview for MORF4 抗体 (Middle Region) (ABIN928181)

抗原

See all MORF4 抗体
MORF4 (Mortality Factor 4 (MORF4))

适用

人, 小鼠, 大鼠, 犬, Cow, 非洲爪蟾, 斑马鱼

宿主

  • 4
  • 2

克隆类型

  • 4
  • 2
多克隆

标记

  • 6
This MORF4 antibody is un-conjugated

应用范围

  • 6
  • 4
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB)
  • 抗原表位

    • 2
    • 2
    • 2
    • 1
    Middle Region

    交叉反应

    小鼠, 大鼠, Frog, 犬, 牛, 斑马鱼

    纯化方法

    Purified

    免疫原

    MORF4 antibody was raised in rabbit using the middle region of MORF4 as the immunogen
  • 应用备注

    WB: 0.2-1 µg/mL
    Optimal conditions should be determined by the investigator.

    说明

    MORF4 Blocking Peptide, (ABIN940199), is also available for use as a blocking control in assays to test for specificity of this MORF4 antibody

    限制

    仅限研究用
  • 状态

    Lyophilized

    浓度

    Lot specific

    缓冲液

    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

    注意事项

    Avoid repeated freeze/thaw cycles.

    储存条件

    4 °C/-20 °C

    储存方法

    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • 抗原

    MORF4 (Mortality Factor 4 (MORF4))

    别名

    MORF4

    背景

    Cellular senescence, the terminal nondividing state that normal cells enter following completion of their proliferative potential, is the dominant phenotype in hybrids of normal and immortal cells. Fusions of immortal human cell lines with each other have led to their assignment to 1 of several complementation groups. MORF4 is a gene on chromosome 4 that induces a senescent-like phenotype in cell lines assigned to complementation group B. Synonyms: Polyclonal MORF4 antibody, Anti-MORF4 antibody, mortality factor 4 antibody, CSR antibody, CSRB antibody, SEN antibody, SEN1 antibody.
You are here:
Chat with us!